3.00Open3.00Pre Close0 Volume1 Open Interest5.00Strike Price0.00Turnover0.00%IV18.70%PremiumAug 16, 2024Expiry Date2.54Intrinsic Value100Multiplier24DDays to Expiry0.46Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma0.97Leverage Ratio--Theta--Rho--Eff Leverage--Vega
InterCure Stock Discussion
NEWS
InterCure Announces FY2023 Results: Revenue of NIS 356 million and Adjusted EBITDA of NIS 61 million
InterCure achieved annual revenue of NIS 356 million and adjusted EBITDA of NIS 61 million, representing 17% of revenues.
The company maintained profitability for the fourteenth and fifteenth consecutive quarters despite challenges.
InterCure continues to expand its product portfolio and dedicated medical cannabis pharmacy chain.
The company is entitled to full compensat...
No comment yet